Calcipotriol cream: A review of its use in the management of psoriasis

References

• Schön M. P., Boehncke W. H. Psoriasis. N Engl J Med 2005; 352: 1899–912
   PubMed Web of Science ®Google Scholar
• Fenton C., Plosker G. L. Calcipotriol/betamethasone dipropionate: A review of its use in the treatment of psoriasis vulgaris. Am J Clin Dermatol 2004; 5: 463–78
   PubMed Web of Science ®Google Scholar
• Lebwohl M., Menter A., Koo J., Feldman S. R. Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol 2004; 50: 416–30
   PubMed Web of Science ®Google Scholar
• Mason J., Mason A. R., Cork M. J. Topical preparations for the treatment of psoriasis: A systematic review. Br J Dermatol 2002; 146: 351–64
   PubMed Web of Science ®Google Scholar
• Berth‐Jones J., Chu A. C., Dodd W. A., Ganpule M., Griffiths W. A., Haydey R. P., et al. A multicentre, parallel‐group comparison of calcipotriol ointment and short‐contact dithranol therapy in chronic plaque psoriasis. Br J Dermatol 1992; 127: 266–71
   PubMed Web of Science ®Google Scholar
• Pinheiro N. Comparative effects of calcipotriol ointment (50 µg/g) and 5% coal tar/2% allantoin/0.5% hydrocortisone cream in treating plaque psoriasis. Br J Clin Pract 1997; 51: 16–19
   PubMedGoogle Scholar
• Veien N. K., Bjerke J. R., Rossmann‐Ringdahl I., Jakobsen H. B. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double‐blind trial. Br J Dermatol 1997; 137: 581–6
   PubMed Web of Science ®Google Scholar
• Scott L. J., Dunn C. J., Goa K. L. Calcipotriol ointment. A review of its use in the management of psoriasis. Am J Clin Dermatol 2001; 2: 95–120
   PubMedGoogle Scholar
• Guilhou J. J. The therapeutic effects of vitamin D3 and its analogues in psoriasis. Expert Opin Investig Drugs 1998; 7: 77–84
   PubMedGoogle Scholar
• Arnold W. P., van de Kerkhof P. C. The induction of epidermal ornithine decarboxylase following tape stripping is inhibited by a topical vitamin D3 analogue (MC903). Br J Dermatol 1991; 125: 6–8
   Google Scholar
• Glade C. P., Van Erp P. E., Van De Kerkhof P. C. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17‐butyrate cream or betamethasone 17‐valerate cream: A comparative flow cytometric study. Br J Dermatol 1996; 135: 379–84
   PubMed Web of Science ®Google Scholar
• Dam T. N., Moller B., Hindkjaer J., Kragballe K. The vitamin D3 analog calcipotriol suppresses the number and antigen‐presenting function of Langerhans cells in normal human skin. J Investig Dermatol Symp Proc 1996; 1: 72–7
   PubMedGoogle Scholar
• Fredriksson T., Pettersson U. Severe psoriasis – oral therapy with a new retinoid. Dermatologica 1978; 157: 238–44
   PubMedGoogle Scholar
• Harrington C. I., Goldin D., Lovell C. R., van de Kerkhof P., Nieboer C., Austad J., et al. Comparative effects of two different calcipotriol (MC903) cream formulations versus placebo in psoriasis vulgaris. A randomised, double‐blind, placebo‐controlled, parallel group multi‐centre study. J Eur Acad Dermatol Venereol 1996; 6: 152–8
   Google Scholar
• Ferrandiz C., Bielsa I., Ribera M., Fuente M. J., Carrascosa J. M. Reinforcement therapy in patients with psoriasis treated with calcipotriol cream. Actas Dermosifiliogr 1998; 89: 626–30
   Google Scholar
• Stadler R., Bohmeyer J. [Regarding the effectiveness and tolerability of a cream containing calcipotriol (Psorcutan®) in the treatment of psoriasis vulgaris.]. Z Hautkr 1998; 73: 593–6
   Google Scholar
• Duweb G., Aldebani S., Elzorghany A., Benghazil M., Alhaddar J. Calcipotriol ointment versus cream in psoriasis vulgaris. Int J Clin Pharmacol Res 2003; 23: 47–51
   PubMedGoogle Scholar
• Van de Kerkhof P. C., Vissers W. H. The topical treatment of psoriasis. Skin Pharmacol Appl Skin Physiol 2003; 16: 69–83
   PubMedGoogle Scholar
• Kragballe K., Barnes L., Hamberg K. J., Hutchinson P., Murphy F., Moller S., et al. Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: Tolerability and efficacy. Br J Dermatol 1998; 139: 649–54
   PubMed Web of Science ®Google Scholar
• Stücker M., Memmel U., Hoffmann M., Hartung J., Altmeyer P. Vitamin B(12) cream containing avocado oil in the therapy of plaque psoriasis. Dermatology 2001; 203: 141–7
   PubMed Web of Science ®Google Scholar
• Molin L., Cutler T. P., Helander I., Nyfors B., Downes N. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17‐valerate cream in the treatment of chronic plaque psoriasis. A randomized, double‐blind, parallel group multicentre study. Br J Dermatol 1997; 136: 89–93
   PubMed Web of Science ®Google Scholar
• Tzaneva S., Hönigsmann H., Tanew A. Observer‐blind, randomized, intrapatient comparison of a novel 1% coal tar preparation (Exorex®) and calcipotriol cream in the treatment of plaque type psoriasis. Br J Dermatol 2003; 149: 350–3
   PubMed Web of Science ®Google Scholar
• White S., Vender R., Thaci D., Swinkels Q., Naeyaert J. M., Foster R., et al. Use of calcipotriene cream (Dovonex® cream) following acute treatment of psoriasis vulgaris with calcipotriene/betamethasone dipropionate two‐compound product (Taclonex®): A randomised, parallel group clinical trial. Am J Clin Dermatol 2006; 7: 177–84
   PubMed Web of Science ®Google Scholar
• Cassano N., Miracapillo A., Coviello C., Lo console F., Bellino M., Vena G. A. Treatment of psoriasis vulgaris with the two‐compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol. Clin Drug Invest 2006; 26: 227–33
   PubMed Web of Science ®Google Scholar
• Barnes L., Altmeyer P., Forstrom L., Stenstrom M. H. Long‐term treatment of psoriasis with calcipotriol scalp solution and cream. Eur J Dermatol 2000; 10: 199–204
   PubMed Web of Science ®Google Scholar
• Ramsay C. A., Berth‐Jones J., Brundin G., Cunliffe W. J., Dubertret L., van de Kerkhof P. C., et al. Long‐term use of topical calcipotriol in chronic plaque psoriasis. Dermatology 1994; 189: 260–4
   PubMed Web of Science ®Google Scholar
• Meyrat R., Mueller I. Daivonex® ointment daily versus Daivonex® cream in the morning and Daivonex® ointment in the evening. Ars Med 1996; 86: 1218–20
   Google Scholar
• Van de Kerkhof P. C., Franssen M., de la Brassine M., Kuipers M. Calcipotriol cream in the morning and ointment in the evening: A novel regimen to improve compliance. J Dermatolog Treat 2001; 12: 75–9
   PubMed Web of Science ®Google Scholar
• Vena G. A., Cassano N., Agnusdei C. P., Bellini M., Calabretta S., Centofanti S., et al. Treatment of psoriasis vulgaris with calcipotriol betamethasone dipropionate combination followed by calcipotriol and assessment of the adjuvant basic use of urea‐based emollients. Eur J Inflamm 2005; 3: 37–42
   Google Scholar
• Schlehaider U. K., Kowalzick L. Cream based calcipotriol for the treatment of ‘inverse’ psoriasis and seborrheic dermatitis. Aktuelle Derm 1996; 22: 345–8
   Google Scholar
• Darley C. R., Cunliffe W. J., Green C. M., Hutchinson P. E., Klaber M. R., Downes N. Safety and efficacy of calcipotriol ointment (Dovonex®) in treating children with psoriasis vulgaris. Br J Dermatol 1996; 135: 390–3
   PubMed Web of Science ®Google Scholar
• Pauluzzi P., Doria A., Nobile C., Trevisan G. Calcipotriol cream in childhood psoriasis. Acta Dermatovenerol Alp Panonica Adriat 1999; 8: 119–21
   Google Scholar
• Duweb G. A., Eldebani S., Alhaddar J. Calcipotriol cream in the treatment of flexural psoriasis. Int J Tissue React 2003; 25: 127–30
   PubMedGoogle Scholar
• Halbaut L., Alcalde M. T., Aróztegui M., Barbé C. [Relation between the physicochemical characteristics and the sensorial properties of topical pharmaceutical products. II Sensorial analysis. ] Cienc Pharm 1996; 6: 289–96
   Google Scholar
• Halbaut L., Alcalde M. T., Aróztegui M., Barbé C. [Sensory analysis and rheological properties: determining factors.]. 1st Mediterranean Congress of Cosmetology: Efficacy and Innocuity: New trends in relation with the European dossier. La Grande Motte, France 1996; 260–80
   Google Scholar
• Lebwohl M., Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol 2001; 45: 487–98
   PubMed Web of Science ®Google Scholar
• Papp K. A., Guenther L., Boyden B., Larsen F. G., Harvima R. J., Guilhou J. J., et al. Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J Am Acad Dermatol 2003; 48: 48–54
   PubMed Web of Science ®Google Scholar
• Douglas W. S., Poulin Y., Decroix J., Ortonne J. P., Mrowietz U., Gulliver W., et al. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol 2002; 82: 131–5
   PubMed Web of Science ®Google Scholar
• Kaufmann R., Bibby A. J., Bissonnette R., Cambazard F., Chu A. C., Decroix J., et al. A new calcipotriol/betamethasone dipropionate formulation (Daivobet®) is an effective once‐daily treatment for psoriasis vulgaris. Dermatology 2002; 205: 389–93
   PubMed Web of Science ®Google Scholar
• Guenther L., van de Kerkhof P. C., Snellman E., Kragballe K., Chu A. C., Tegner E., et al. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: A randomized, double‐blind, vehicle‐controlled clinical trial. Br J Dermatol 2002; 147: 316–23
   PubMed Web of Science ®Google Scholar
• Kragballe K., Noerrelund K. L., Lui H., Ortonne J. P., Wozel G., Uurasmaa T., et al. Efficacy of once‐daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris. Br J Dermatol 2004; 150: 1167–73
   PubMed Web of Science ®Google Scholar